drug · small molecule
bemcentinib
Phase 2updated 3mo agoby Oncoinvent ASA🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 10 investigational indications.
indications
indications
NSCLC
targets
Tyrosine-protein kinase receptor UFO
all catalysts(0)
nothing on the calendar yet
Trials studying bemcentinib
- phase2A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene
- phase2Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- phase2A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
- phase1A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
- phase2A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
- phase2A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients
- phase2Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that